Integrated analysis of mRNA and miRNA expression in response to interleukin-6 in hepatocytes

Genomics

Volumn 106, Issue 2, 2015, Pages 107-115

  Lukowski, Samuel W ^a,b   Fish, Richard J ^a,b   Martin Levilain, Juliette ^a   Gonelle Gispert, Carmen ^c   Bühler, Leo H ^c   Maechler, Pierre ^a   Dermitzakis, Emmanouil T ^a,b,d   Neerman Arbez, Marguerite ^a,b  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^b Institute of Genetics and Genomics in Geneva (iGE3)   (Switzerland)

^c UNIVERSITY HOSPITAL   (Switzerland)

^d SWISS INSTITUTE OF BIOINFORMATICS   (Switzerland)

Author keywords

Acute phase response; Hepatocyte; IL 6; Inflammation; MiRNA; Post transcriptional regulation; Transcriptome

Indexed keywords

ACUTE PHASE PROTEIN; INTERLEUKIN 6; MESSENGER RNA; MICRORNA; TRANSCRIPTOME;

3' UNTRANSLATED REGION; ACUTE PHASE RESPONSE; ANIMAL CELL; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; GENE EXPRESSION; GENETIC ANALYSIS; HEPG2 CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; LIVER CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RNA SEQUENCE; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TRANSCRIPTOMICS; ANIMAL; BIOSYNTHESIS; CELL CULTURE; DRUG EFFECTS; GENETICS; METABOLISM;

ACUTE-PHASE PROTEINS; ANIMALS; CELLS, CULTURED; HEP G2 CELLS; HEPATOCYTES; HUMANS; INTERLEUKIN-6; MICE; MICRORNAS; RNA, MESSENGER; TRANSCRIPTOME;

EID: 84934942767     PISSN: 08887543     EISSN: 10898646     Source Type: Journal    
DOI: 10.1016/j.ygeno.2015.05.001     Document Type: Article

References (51)

1. Baumann H., Prowse K.R., Marinković S., Won K.A., Jahreis G.P. Stimulation of hepatic acute phase response by cytokines and glucocorticoids. Ann. N. Y. Acad. Sci. 1989, 557:280-296.
2. Gabay C., Kushner I. Acute-phase proteins and other systemic responses to inflammation. N. Engl. J. Med. 1999, 340:448-454.
3. Gabay C., Kushner I. Acute phase proteins. eLS 2001, John Wiley & Sons, Ltd, Chichester.
4. Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies. Lancet 2012, 379:1205-1213. IL6R Genetics Consortium Emerging Risk Factors Collaboration.
5. Huber S.A., Sakkinen P., Conze D., Hardin N., Tracy R. Interleukin-6 exacerbates early atherosclerosis in mice. Arterioscler. Thromb. Vasc. Biol. 1999, 19:2364-2367.
6. Pradhan A.D., Manson J.E., Rifai N., Buring J.E., Ridker P.M. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001, 286:327-334.
7. Spranger J., Kroke A., Möhlig M., Hoffmann K., Bergmann M.M., Ristow M., Boeing H., Pfeiffer A.F.H. Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes 2003, 52:812-817.
8. Houssiau F.A., Devogelaer J.P., Van Damme J., de Deuxchaisnes C.N., Van Snick J. Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides. Arthritis Rheum. 1988, 31:784-788.
9. Usón J., Balsa A., Pascual-Salcedo D., Cabezas J.A., Gonzalez-Tarrio J.M., Martín-Mola E., Fontan G. Soluble interleukin 6 (IL-6) receptor and IL-6 levels in serum and synovial fluid of patients with different arthropathies. J. Rheumatol. 1997, 24:2069-2075.
10. Waage A., Kaufmann C., Espevik T., Husby G. Interleukin-6 in synovial fluid from patients with arthritis. Clin. Immunol. Immunopathol. 1989, 50:394-398.
11. Humbert M., Monti G., Brenot F., Sitbon O., Portier A., Grangeot-Keros L., Duroux P., Galanaud P., Simonneau G., Emilie D. Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension. Am. J. Respir. Crit. Care Med. 1995, 151:1628-1631.
12. Soon E., Holmes A.M., Treacy C.M., Doughty N.J., Southgate L., Machado R.D., Trembath R.C., Jennings S., Barker L., Nicklin P., et al. Elevated levels of inflammatory cytokines predict survival in idiopathic and familial pulmonary arterial hypertension. Circulation 2010, 122:920-927.
13. Chinnaiyan A.M., Huber-Lang M., Kumar-Sinha C., Barrette T.R., Shankar-Sinha S., Sarma V.J., Padgaonkar V.A., Ward P.A. Molecular signatures of sepsis: multiorgan gene expression profiles of systemic inflammation. Am. J. Pathol. 2001, 159:1199-1209.
14. Coulouarn C., Lefebvre G., Daveau R., Letellier F., Hiron M., Drouot L., Daveau M., Salier J.-P. Genome-wide response of the human Hep3B hepatoma cell to proinflammatory cytokines, from transcription to translation. Hepatology 2005, 42:946-955.
15. Coulouarn C., Lefebvre G., Derambure C., Lequerre T., Scotte M., Francois A., Cellier D., Daveau M., Salier J.-P. Altered gene expression in acute systemic inflammation detected by complete coverage of the human liver transcriptome. Hepatology 2004, 39:353-364.
16. Cubedo J., Padró T., Badimon L. Coordinated proteomic signature changes in immune response and complement proteins in acute myocardial infarction: the implication of serum amyloid P-component. Int. J. Cardiol. 2013, 168:5196-5204.
17. Nakata K., Saitoh R., Amano J., Ichibangase T., Ishigai M., Imai K. Comprehensive and temporal analysis of secreted proteins in the medium from IL-6 exposed human hepatocyte. Biomed. Chromatogr. 2014, 28:742-750.
18. Nakata K., Saitoh R., Amano J., Koshiyama A., Ichibangase T., Murao N., Ohta K., Aso Y., Ishigai M., Imai K. Alteration of intracellular secretory acute phase response proteins expressed in human hepatocyte induced by exposure with interleukin-6. Cytokine 2012, 59:317-323.
19. Thacker S.A., Robinson P., Abel A., Tweardy D.J. Modulation of the unfolded protein response during hepatocyte and cardiomyocyte apoptosis in trauma/hemorrhagic shock. Sci. Rep. 2013, 3:1187.
20. Pochareddy S., Edenberg H.J. Chronic alcohol exposure alters gene expression in HepG2 cells. Alcohol. Clin. Exp. Res. 2012, 36:1021-1033.
21. Van Dycke K.C., Nijman R.M., Wackers P.F., Jonker M.J., Rodenburg W., van Oostrom C.T., Salvatori D.C., Breit T.M., van Steeg H., Luijten M., et al. A day and night difference in the response of the hepatic transcriptome to cyclophosphamide treatment. Arch. Toxicol. 2015, 89:221-231.
22. Matsumoto S., Sakata Y., Suna S., Nakatani D., Usami M., Hara M., Kitamura T., Hamasaki T., Nanto S., Kawahara Y., et al. Circulating p53-responsive microRNAs are predictive indicators of heart failure after acute myocardial infarction. Circ. Res. 2013, 113:322-326.
23. Courboulin A., Paulin R., Giguère N.J., Saksouk N., Perreault T., Meloche J., Paquet E.R., Biardel S., Provencher S., Côté J., et al. Role for miR-204 in human pulmonary arterial hypertension. J. Exp. Med. 2011, 208:535-548.
24. Wang G., Tam L.S., Li E.K.M., Kwan B.C.H., Chow K.M., Luk C.C.W., Li P.K.T., Szeto C.C. Serum and urinary free microRNA level in patients with systemic lupus erythematosus. Lupus 2011, 20:493-500.
25. Gailhouste L., Gomez-Santos L., Hagiwara K., Hatada I., Kitagawa N., Kawaharada K., Thirion M., Kosaka N., Takahashi R.-u., Shibata T., et al. miR-148a plays a pivotal role in the liver by promoting the hepatospecific phenotype and suppressing the invasiveness of transformed cells. Hepatology 2013, 58:1153-1165.
26. Camps C., Saini H.K., Mole D.R., Choudhry H., Reczko M., Guerra-Assunção J., Tian Y.-M., Buffa F.M., Harris A.L., Hatzigeorgiou A.G., et al. Integrated analysis of microRNA and mRNA expression and association with HIF binding reveals the complexity of microRNA expression regulation under hypoxia. Mol. Cancer 2014, 13:28.
27. Brock M., Trenkmann M., Gay R.E., Gay S., Speich R., Huber L.C. MicroRNA-18a enhances the interleukin-6-mediated production of the acute-phase proteins fibrinogen and haptoglobin in human hepatocytes. J. Biol. Chem. 2011, 286:40142-40150.
28. Zhang Y., Zhang B., Zhang A., Li X., Liu J., Zhao J., Zhao Y., Gao J., Fang D., Rao Z. IL-6 upregulation contributes to the reduction of miR-26a expression in hepatocellular carcinoma cells. Braz. J. Med. Biol. Res. 2013, 46:32-38.
29. Nguyen T.H., Oberholzer J., Birraux J., Majno P., Morel P., Trono D. Highly efficient lentiviral vector-mediated transduction of nondividing, fully reimplantable primary hepatocytes. Mol. Ther. 2002, 6:199-209.
30. Klaunig J.E., Goldblatt P.J., Hinton D.E., Lipsky M.M., Trump B.F. Mouse liver cell culture. II. Primary culture. In Vitro 1981, 17:926-934.
31. Kim D., Pertea G., Trapnell C., Pimentel H., Kelley R., Salzberg S.L. TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol. 2013, 14:R36.
32. Anders S., Pyl P.T., Huber W. HTSeq-a Python framework to work with high-throughput sequencing data. Bioinformatics 2015, 31:166-169.
33. Robinson M.D., McCarthy D.J., Smyth G.K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 2010, 26:139-140.
34. Kamburov A., Stelzl U., Lehrach H., Herwig R. The ConsensusPathDB interaction database: 2013 update. Nucleic Acids Res. 2013, 41:D793-D800.
35. Kamburov A., Wierling C., Lehrach H., Herwig R. ConsensusPathDB-a database for integrating human functional interaction networks. Nucleic Acids Res. 2009, 37:D623-D628.
36. Plaisier C.L., Bare J.C., Baliga N.S. miRvestigator: web application to identify miRNAs responsible for co-regulated gene expression patterns discovered through transcriptome profiling. Nucleic Acids Res. 2011, 39:W125-W131.
37. Bode J.G., Heinrich P.C. Interleukin-6 signaling during the acute-phase response of the liver. Liver Biol. Pathobiol. 2001, 4:565-580.
38. Gordon A.H., Koj A. Changes in the rates of synthesis of certain plasma proteins following tissue damage due to talc injection. A study using the perfused rat liver. Br. J. Exp. Pathol. 1968, 49:436-447.
39. Olivier E., Soury E., Risler J.L., Smih F., Schneider K., Lochner K., Jouzeau J.Y., Fey G.H., Salier J.P. A novel set of hepatic mRNAs preferentially expressed during an acute inflammation in rat represents mostly intracellular proteins. Genomics 1999, 57:352-364.
40. Warwas M., Osada J. Changes of the level of proteinase inhibitors in rat plasma during turpentine-induced inflammation. Experientia 1985, 41:633-634.
41. Lukowski S.W., Fish R.J., Martin-Levilain J., Gonelle-Gispert C., Bühler L.H., Maechler P., Dermitzakis E.T., Neerman-Arbez M. Integrated analysis of mRNA and miRNA expression in response to interleukin-6 in hepatocytes. Data in Brief 2015, (submitted).
42. Lewis B.P., Burge C.B., Bartel D.P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 120:15-20.
43. Baumjohann D., Kageyama R., Clingan J.M., Morar M.M., Patel S., de Kouchkovsky D., Bannard O., Bluestone J.A., Matloubian M., Ansel K.M., et al. The microRNA cluster miR-17~92 promotes TFH cell differentiation and represses subset-inappropriate gene expression. Nat. Immunol. 2013, 14:840-848.
44. Hu W., Wang T., Yue E., Zheng S., Xu J.H. Flexible microRNA arm selection in rice. Biochem. Biophys. Res. Commun. 2014, 447:526-530.
45. Tilg H., Trehu E., Atkins M.B., Dinarello C.A., Mier J.W. Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55. Blood 1994, 83:113-118.
46. Brock M., Trenkmann M., Gay R.E., Michel B.A., Gay S., Fischler M., Ulrich S., Speich R., Huber L.C. Interleukin-6 modulates the expression of the bone morphogenic protein receptor type II through a novel STAT3-microRNA cluster 17/92 pathway. Circ. Res. 2009, 104:1184-1191.
47. Brockhausen J., Tay S.S., Grzelak C.A., Bertolino P., Bowen D.G., d'Avigdor W.M., Teoh N., Pok S., Shackel N., Gamble J.R., et al. miR-181a mediates TGF-beta-induced hepatocyte EMT and is dysregulated in cirrhosis and hepatocellular cancer. Liver Int. 2015, 35:240-253.
48. Collins A.S., McCoy C.E., Lloyd A.T., O'Farrelly C., Stevenson N.J. miR-19a: an effective regulator of SOCS3 and enhancer of JAK-STAT signalling. PLoS ONE 2013, 8:e69090.
49. Gantier M.P., Stunden H.J., McCoy C.E., Behlke M.A., Wang D., Kaparakis-Liaskos M., Sarvestani S.T., Yang Y.H., Xu D., Corr S.C., et al. A miR-19 regulon that controls NF-κB signaling. Nucleic Acids Res. 2012, 40:8048-8058.
50. Skinner J.P.J., Keown A.A., Chong M.M.W. The miR-17~92a cluster of microRNAs is required for the fitness of Foxp3+ regulatory T cells. PLoS ONE 2014, 9:e88997.
51. Xie W., Li M., Xu N., Lv Q., Huang N., He J., Zhang Y. miR-181a regulates inflammation responses in monocytes and macrophages. PLoS ONE 2013, 8:e58639.